Previous close | 6.25 |
Open | 6.08 |
Bid | 5.05 |
Ask | 7.15 |
Strike | 22.50 |
Expiry date | 2025-01-17 |
Day's range | 6.08 - 6.15 |
Contract range | N/A |
Volume | |
Open interest | 3.74k |
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
As the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a Citi analyst who hasn’t recommended the stock in over a decade. But Andrew Baum has something Pfizer needs: oncology expertise.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE).